Sign In
Buy ACAD
$22.60
+0.510 (+2.31%)
At Close: Jun 23, 2026
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and CTI BioPharma (CTIC)
06:27pm, Monday, 27'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurocrine (NBIX) and CTI BioPharma (CTIC). Neurocrine (NBIX) In a
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and CTI BioPharma (NASDAQ: CTIC)
06:27pm, Monday, 27'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurocrine (
NBIX
–
Research Report
) and CTI BioPharma (
CTIC
–
Research Report
).
Neurocrine (NBIX)
In a report
Needham Gives a Hold Rating to Lexicon Pharmaceuticals (LXRX)
04:19pm, Monday, 27'th Apr 2020
In a report released today, Alan Carr from Needham assigned a Hold rating to Lexicon Pharmaceuticals (LXRX). The company's shares closed last Monday at
Needham Gives a Hold Rating to Lexicon Pharmaceuticals (LXRX)
04:19pm, Monday, 27'th Apr 2020
In a report released today,
Alan Carr
from Needham assigned a
Hold
rating to Lexicon Pharmaceuticals (
LXRX
–
Research Report
). The company’s shares closed last Monday at $2.26.
According to
TipR
Stocks Are Set To Rise On April 27 But Are Going Nowhere Fast
01:06pm, Monday, 27'th Apr 2020
The good news is that stocks are pointing to a higher opening on April 27.
$93.20 Million in Sales Expected for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) This Quarter
09:38am, Monday, 27'th Apr 2020
Equities analysts expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to post sales of $93.20 million for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made esti
Fly Insider: Accelerate Diagnostics, Abbott among week's notable insider trades MYOV;AIMT;AXDX;CFG;VOXX;KMB;PGNY;EBS;ABT;ACAD
06:41am, Monday, 27'th Apr 2020
Fly Insider: Accelerate Diagnostics, Abbott among week's notable insider trades MYOV AIMT AXDX CFG VOXX KMB PGNY EBS ABT ACAD
Oppenheimer Believes Amgen (AMGN) Won't Stop Here
12:03am, Monday, 27'th Apr 2020
In a report released yesterday, Jay Olson from Oppenheimer maintained a Buy rating on Amgen (AMGN), with a price target of $250.00. The company's shares
Oppenheimer Believes Amgen (NASDAQ: AMGN) Won’t Stop Here
12:03am, Monday, 27'th Apr 2020
In a report released yesterday,
Jay Olson
from Oppenheimer maintained a
Buy
rating on Amgen (
AMGN
–
Research Report
), with a price target of
$250.00
. The company’s shares closed last Friday at
Stocks Are Set To Rise On April 27 But Are Going Nowhere Fast
12:00am, Monday, 27'th Apr 2020Many students lack access to internet for remote learning
04:01am, Sunday, 26'th Apr 2020
BATON ROUGE, La. (AP) — The majority of students in half of Louisiana’s school districts do not have internet at their homes, illuminating a major challenge of shifting to remote learning as schoo
Zacks: Brokerages Anticipate ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Announce -$0.46 Earnings Per Share
06:26am, Saturday, 25'th Apr 2020
Analysts expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to post ($0.46) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estim
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Acadia Healthcare
Oppenheimer Gives a Hold Rating to Prothena (PRTA)
03:41pm, Thursday, 23'rd Apr 2020
In a report released today, Jay Olson from Oppenheimer assigned a Hold rating to Prothena (PRTA). The company's shares closed last Thursday at $11.50.
Oppenheimer Gives a Hold Rating to Prothena (PRTA)
03:41pm, Thursday, 23'rd Apr 2020
In a report released today,
Jay Olson
from Oppenheimer assigned a
Hold
rating to Prothena (
PRTA
–
Research Report
). The company’s shares closed last Thursday at $11.50.
According to
TipRanks.com
